Medical Oncology Publications

October 20262 publications

Authors	Date Published	Journal	Title
Kelsey Pan Ticiana Leal	10/14/2026	Cancer	Redefining leptomeningeal metastasis in non-small cell lung cancer: From terminal complication to molecularly managed disease.
Nabil F Saba	10/04/2026	Oral oncology	Prognostic value of baseline modified barium swallow for perioperative dysphagia in oropharyngeal cancer: Secondary analysis of ECOG-ACRIN E3311.

September 202619 publications

Authors	Date Published	Journal	Title
Ravi B Parikh	09/24/2026	The Lancet. Oncology	Counting who was not tested: artificial intelligence extraction of genomic and treatment data from hospital records.
K Kalinsky	09/16/2026	Annals of oncology : official journal of the European Society for Medical Oncology	Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.
Nabil F Saba	09/14/2026	Cancer	A systematic review of international/national guidelines for the management of nasopharyngeal carcinoma: Convergence and divergence of recommendations.
Jane Meisel	09/13/2026	JMIR formative research	Health Literacy and Capecitabine Adherence in a Remote Monitoring Pilot Trial for Breast Cancer: Post Hoc Exploratory Analysis.
Jennifer Carlisle Suresh S Ramalingam	09/10/2026	Science advances	Early detection of invasive lung cancer and multiorgan metastasis by a collagen-targeted protein MRI contrast agent.
Jane Meisel	09/08/2026	Breast cancer research and treatment	Real-world estrogen receptor alpha 1 (ESR1) testing patterns and results for ER+/HER2- metastatic breast cancer in the United States, 2018-2024.
Jane L Meisel	09/08/2026	Breast cancer research and treatment	Real-world treatment patterns and clinical outcomes in patients with emerging estrogen receptor 1 (ESR1)-mutated ER+ metastatic breast cancer in the U.S., 2018-2024.
Suresh S Ramalingam	09/08/2026	Clinical cancer research : an official journal of the American Association for Cancer Research	Osimertinib After Definitive Chemoradiotherapy in Unresectable Stage III EGFR-Mutated NSCLC: Subsequent Treatments and PPO From the Phase III LAURA Study.
N Iyengar	09/07/2026	ESMO open	Randomised phase III trials of cancer prevention drugs: a systematic review and prediction of trial success.
Manali A Bhave	09/07/2026	Molecular diagnosis & therapy	Bridging Biomarker Testing to Biomarker-Driven Targeted Therapy: Real-World ESR1 Mutation Testing Patterns and Prevalence in ER+, HER2- Metastatic Breast Cancer.
Nabil F Saba	09/05/2026	Head & neck	Blueberry Extract Has Anti-Proliferative Activity in Preclinical Models of Head and Neck Cancer.
Conor E Steuer	09/05/2026	Lancet (London, England)	Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.
Mehmet Asim Bilen	09/04/2026	Prostate cancer and prostatic diseases	Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer.
Ravi B Parikh	09/03/2026	Journal of clinical oncology : official journal of the American Society of Clinical Oncology	Breast Cancer Risk Assessment Has a Data Integration Problem: Can Artificial Intelligence Solve It?
Jordan Ciuro Mehmet Asim Bilen Bradley Carthon Jacqueline Brown Jacob Berchuck Ravi Parikh Omer Kucuk	09/02/2026	Clinical genitourinary cancer	Efficacy and Safety of Every Other Week Gemcitabine and Docetaxel (GEMDOC) in Heavily Pretreated Metastatic Castration Resistant Prostate Cancer: A Retrospective Real-world Analysis.
K Kalinsky	08/31/2026	Annals of oncology : official journal of the European Society for Medical Oncology	Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Conor E Steuer Nabil F Saba	08/31/2026	Cancer medicine	The Molecular and Immunological Landscape in Nasopharyngeal Carcinoma (NPC) Differs by Somatostatin Receptor 2 (SSTR2) Expression.
Kevin M Kalinsky	08/31/2026	Clinical advances in hematology & oncology : H&O	The use of genomic assays to guide chemotherapy in breast cancer.
Ravi B Parikh	08/31/2026	Health affairs scholar	Streamlining oversight in Medicare advantage: measuring coding intensity via contract rankings.

August 202618 publications

Authors	Date Published	Journal	Title
Kevin Kalinsky	08/30/2026	Targeted oncology	Risk of Recurrence in Patients with HR+/HER2- Early Breast Cancer: A Podcast.
Nabil F Saba	08/26/2026	JAMA otolaryngology-- head & neck surgery	Imaging-Detected Extranodal Extension in p16-Positive Oropharyngeal Cancer: Secondary Analysis of RTOG 1016.
David H Lawson	08/24/2026	The Journal of clinical investigation	B-cell depletion improves therapeutic index of combination checkpoint blockade in patients with advanced melanoma.
Ticiana A Leal Suresh S Ramalingam	08/24/2026	The Lancet. Respiratory medicine	Crizotinib versus observation or placebo for surgically resected early-stage ALK-positive non-small-cell lung cancer (Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E4512): a phase 3 trial.
Daniel M Halperin	08/21/2026	European journal of cancer (Oxford, England : 1990)	Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.
Nabil F Saba	08/18/2026	Clinical cancer research : an official journal of the American Association for Cancer Research	Danvatirsen plus pembrolizumab versus pembrolizumab for recurrent and/or metastatic head and neck squamous cell carcinoma (PEMDA-HN): a randomized, phase 2 trial.
Ticiana A Leal	08/17/2026	Clinical cancer research : an official journal of the American Association for Cancer Research	Longitudinal Phenotyping of Circulating Tumor Cells using a Scalable Deep Learning Framework.
Jacob E Berchuck	08/17/2026	The Journal of clinical investigation	Polycomb Scaffolding Subunit EED Supports the SCLC Neuroendocrine Identity and EGFR-Mutant LUAD to SCLC Transformation.
Oluwadunni Emiloju Gideon T Dosunmu Olumide Gbolahan Olatunji B Alese	08/14/2026	Cancer	Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.
Demetria Smith Graziani Kevin Kalinsky	08/14/2026	Cancer	Top advances of the year: Breast cancer.
Demetria Smith-Graziani Kevin Kalinsky	08/14/2026	Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer	Factors influencing acupuncture regimen completion by breast cancer patients: real-world data from an NCI-designated comprehensive cancer center.
Shipra Gandhi	08/11/2026	Breast (Edinburgh, Scotland)	Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancer.
Shipra Gandhi	08/09/2026	Annals of surgical oncology	ASO Author Reflections: Neuron Projection Guidance-A transcriptomic perspective on tumor-induced neural recruitment in breast cancer.
Mehmet Asim Bilen	08/06/2026	European journal of cancer (Oxford, England : 1990)	A stromal-immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study.
Ravi B Parikh	08/06/2026	Nature reviews. Clinical oncology	AI-based augmentation of oncology clinical trials.
Shipra Gandhi	08/05/2026	Annals of surgical oncology	ASO Visual Abstract: A Neuron Projection Guidance Signature Associates With Immune-Cold Tumor Microenvironment and Poor Outcomes in Breast Cancer.
Nabil F Saba	08/05/2026	Journal of clinical oncology : official journal of the American Society of Clinical Oncology	Reply to: Therapeutic Strategy Concerns for <i>BRAF</i> V600E-Mutated Differentiated Thyroid Cancer.
Gideon T Dosunmu	08/03/2026	Breast cancer research and treatment	Birth cohort differences in reproductive and lifestyle breast cancer risk factors among women in the Nigerian breast cancer study.

July 202626 publications

Authors	Date Published	Journal	Title
Jane L Meisel	07/29/2026	Breast cancer research and treatment	Association between self-reported breast cancer knowledge and clinical trial participation in patients with triple-negative breast cancer.
Suresh S Ramalingam	07/29/2026	EMBO molecular medicine	Inhibition of PGC1β-dependent mitochondrial biogenesis enhances EGFR-targeted therapy in lung cancer.
Kevin M Kalinsky	07/29/2026	JAMA oncology	Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk ERBB2-Negative Breast Cancer: The I-SPY2 Randomized Clinical Trial.
Ticiana Leal	07/29/2026	Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer	Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.
Elizabeth Sakach Kevin Kalinsky Shipra Gandhi	07/27/2026	Drugs	Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2- Advanced Breast Cancer.
Shipra Gandhi	07/24/2026	Annals of surgical oncology	A Neuron Projection Guidance Signature Associates with Immune-Cold Tumor Microenvironment and Poor Outcomes in Breast Cancer.
K Kalinsky	07/23/2026	ESMO open	Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive HER2-negative breast cancer: safety and patient-reported outcomes from the phase III TROPION-Breast01 study.
Omer Kucuk	07/22/2026	Nutrients	Nutraceuticals in Uro-Oncology: A Structured Expert Review and Precision-Oriented Framework.
Nabil F Saba	07/20/2026	JCO oncology practice	Tobacco Use and Cessation Patterns Among Cancer Survivors: Results From Nine ECOG-ACRIN Cancer Research Group Trials.
Ticiana Leal	07/17/2026	Clinical lung cancer	Immunotherapy in Patients With Small-Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome: A Multi-institutional Case Series.
Kevin Kalinsky	07/15/2026	JAMA oncology	Progression-Free Survival in Metastatic Breast Cancer by Local Investigators vs Blinded Independent Central Review: A Systematic Review and Meta-Analysis.
Kevin Kalinsky	07/14/2026	Journal of the National Cancer Institute	Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007).
Omer Kucuk	07/14/2026	Nutrients	Lycopene, Carotenoids, and Retinoids in Cancer Chemoprevention: Molecular Mechanisms and Clinical Implications.
Daniel M Halperin	07/12/2026	Endocrine-related cancer	Grade Progression and High-Grade Transformation in Neuroendocrine Neoplasms.
Kevin Kalinsky	07/12/2026	The Lancet. Oncology	Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial.
Jacqueline T Brown Bassel Nazha Jacob E Berchuck Ravi Bharat Parikh Jordan Alana Ciuro Omer Kucuk Bradley Curtis Carthon Mehmet Asim Bilen	07/10/2026	The oncologist	Novel Risk Scoring System for Patients with Metastatic Castration Resistant Prostate Cancer Treated with Lutetium-177-PSMA-617.
Suresh S Ramalingam	07/09/2026	Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer	Phase 3 Study of Niraparib-Plus-Pembrolizumab as Maintenance Therapy for Advanced/Metastatic Non-Small Cell Lung Cancer (ZEAL-1L).
Neil M Iyengar	07/08/2026	Cancer research	Obesity and Age Elevate Tissue-Resident Microbiota Akkermansia muciniphila to Induce Oxidative Stress and Promote Breast Cancer Risk.
Nabil Saba	07/08/2026	Head & neck	Immunotherapeutic Approaches to Head and Neck Squamous Cell Carcinoma: Current Clinical Practice and Future Directions.
Neil M Iyengar	07/08/2026	JAMA	Review of Obesity and Cancer-Reply.
Jennifer W Carlisle Conor E Steuer Fatemeh Ardeshir-Larijani Ticiana Leal	07/07/2026	JCO oncology practice	Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine Neoplasms.
Kevin Kalinsky Shipra Gandhi	07/06/2026	Journal of the National Cancer Institute	Racial and ethnic disparities in clinical outcomes of HER2-positive metastatic breast cancer treated with antibody-drug conjugates.
Neil M Iyengar	07/01/2026	World journal of surgical oncology	Oncologic outcomes after poly-4-hydroxybutyrate scaffold in post-mastectomy breast reconstruction: a retrospective, multi-center cohort study.
Suresh S Ramalingam	06/30/2026	Cancer	"Protected time" for clinical investigators in medical oncology: The persistent gap between expectation and reality.
Suresh S Ramalingam	06/30/2026	JAMA network open	Closing the Gap in Lung Cancer Outcomes-Medicaid Expansion for Communities With the Most to Gain.
Olumide Gbolahan	06/30/2026	Journal of clinical oncology : official journal of the American Society of Clinical Oncology	Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

June 202619 publications

Authors	Date Published	Journal	Title
Olumide B Gbolahan	06/29/2026	Clinical cancer research : an official journal of the American Association for Cancer Research	A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.
Suresh S Ramalingam	06/25/2026	Clinical cancer research : an official journal of the American Association for Cancer Research	Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.
Nabil F Saba	06/23/2026	Cancer treatment reviews	Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.
R L Sacks	06/19/2026	Annals of oncology : official journal of the European Society for Medical Oncology	SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Nabil F Saba	06/14/2026	Cancer metastasis reviews	Strategies and successes of smoking cessation methods in head and neck cancer patients: a systematic review.
Kevin Kalinsky	06/14/2026	Clinical breast cancer	Refining Stratification in Premenopausal Node-Positive HR<sup>+</sup>/HER2<sup>-</sup> Breast Cancer With a Novel AI-Based Test.
Daniel M Halperin	06/14/2026	The oncologist	Robust response to pembrolizumab in Temozolomide-Associated Hypermutated and Microsatellite Instability-High Functional Pancreatic Neuroendocrine Tumor.
Mehmet A Bilen	06/14/2026	Urology practice	Contemporary Validation of the Renal Cell Carcinoma Inflammatory Score (RISK) for Preoperative Prognostication in Non-Metastatic Renal Cell Carcinoma.
Nabil F Saba	06/10/2026	Biomarker research	Mitochondrial transfer between tumor and immune cells: a nexus of metabolic adaptation and immune dysfunction.
Ravi B Parikh	06/10/2026	JAMA	When Patients Share Everything With an AI Chatbot: Risks and Opportunities of Large Language Models.
Daniel M Haperin	06/07/2026	Endocrine-related cancer	Primary tumor resection in the setting of unresectable metastatic disease in small bowel NETs: consensus and controversy.
Kevin Kalinsky	06/07/2026	NPJ breast cancer	SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer.
Suresh S Ramalingam	06/05/2026	Lung cancer (Amsterdam, Netherlands)	Osimertinib after definitive CRT in unresectable stage III EGFR-mutated NSCLC: safety outcomes from the phase III LAURA study.
Ticiana A Leal	06/02/2026	Journal of clinical oncology : official journal of the American Society of Clinical Oncology	Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.
Demetria Smith-Graziani	06/02/2026	Journal of the American Geriatrics Society	Research Letter: Frailty Within a Cohort of Older Adults With Breast Cancer: Groundwork for Future Geriatric-Specific Outcomes Data.
Kevin Kalinsky	05/31/2026	American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting	Navigating Treatment Decisions in Early-Stage Hormone Receptor-Positive Breast Cancer.
Elizabeth A Sakach Jane L Meisel	05/31/2026	Cancer	Antibody-drug conjugates in breast cancer.
Nabil F Saba	05/31/2026	Cancer medicine	Predicting Post-Radiotherapy Epigenetic Age Acceleration From Pre-Treatment Data Using a Machine Learning Framework in Head and Neck Cancer Patients.
Suresh S Ramalingam	05/31/2026	JAMA	Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial.

May 202625 publications

Authors	Date Published	Journal	Title
Neil M Iyenger	05/28/2026	Cardio-oncology (London, England)	Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.
Neil M Iyenger	05/28/2026	Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer	Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.
Shipra Gandhi	05/27/2026	Annals of surgical oncology	ASO Author Reflections: Neuronal Signature Enrichment Distinguishes a Type of Gastric Cancer with Poor Prognosis.
K Kalinsky	05/26/2026	ESMO open	Safety analyses of the INAVO120 randomised phase III trial of inavolisib or placebo with palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative, endocrine-resistant advanced breast cancer.
Olumide B Gbolahan	05/22/2026	Cancers	Molecular Characterization of Small Extracellular Vesicles in Pancreatic Cancer Patients Treated with Neoadjuvant Chemotherapy Followed by Stereotactic Body Radiation.
Shipra Gandhi	05/21/2026	Breast cancer research : BCR	TP53 mutation is associated with shorter treatment duration with CDK4/6 inhibitors, but not with immune checkpoint inhibitors, in ER-positive/HER2-negative breast cancer: real-world perspective.
M A Bilen	05/18/2026	ESMO open	EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma.
Mehmet A Bilen	05/17/2026	Clinical cancer research : an official journal of the American Association for Cancer Research	Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial.
Suresh Ramalingam	05/12/2026	Nature cancer	Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial.
Kevin Kalinsky	05/11/2026	medRxiv : the preprint server for health sciences	Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer Recurrence.
Mehmet Asim Bilen	05/09/2026	bioRxiv : the preprint server for biology	Single-Cell Atlas of Renal Cell Carcinoma Brain Metastasis Uncovers Mechanisms of Immune Dysfunction and Resistance.
Suresh S Ramalingam	05/06/2026	Current problems in cancer	Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer.
Mehmet Asim Bilen	05/05/2026	bioRxiv : the preprint server for biology	Deciphering the Genomic Landscape of Renal Cell Carcinoma Brain Metastases.
Neil Iyengar	05/04/2026	Clinical cancer research : an official journal of the American Association for Cancer Research	Benralizumab relieves Eosinophil-Related Cutaneous Adverse Events from Cancer Therapy: A Nonrandomized Phase 2 Trial.
Jennifer Carlisle	05/04/2026	Clinical lung cancer	Real World Outcomes for the Efficacy and Safety of Osimertinib in Black Patients With Nonsmall Cell Lung Cancer.
Nabil F Saba	05/02/2026	Advanced science (Weinheim, Baden-Wurttemberg, Germany)	GLS1 Orchestrates Exosome-Mediated Tumor-Endothelial Communication to Facilitate Angiogenesis.
Shipra Gandhi	05/01/2026	European journal of cancer (Oxford, England : 1990)	MuTriM: A multiscale deep learning model integrating longitudinal radiomics and pathomic features for predicting recurrence and adjuvant radiation benefit in breast cancer.
K Kalinsky	04/30/2026	Annals of oncology : official journal of the European Society for Medical Oncology	Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive, HER2-negative breast cancer: final overall survival analysis of the phase III TROPION-Breast01 study.
R Sacks S Gandhi	04/30/2026	Annals of oncology : official journal of the European Society for Medical Oncology	Is more always better? Low-dose pembrolizumab as a practical step toward more equitable triple-negative breast cancer care.
Olatunji B Alese	04/30/2026	Cancer nursing	Perceptions and Needs for a Technology-Based Dyadic Intervention on Symptom Management Among Patients With Colorectal Cancer and Their Caregivers: A Qualitative Study.
Daniel M Halperin	04/30/2026	Cancers	Clinical Validity of NETest2.0<sup>®</sup> in Surveillance of Neuroendocrine Tumor Patients: Evidence from a NET Registry Study (NCT02270567).
Daniel M Halperin Olatunji B Alese	04/30/2026	Cardio-oncology (London, England)	Survival trends in the management of carcinoid heart disease among patients with neuroendocrine neoplasms.
Conor E Steuer Nabil F Saba	04/30/2026	Head & neck	Minimizing Chemoradiation Using a Surgical Algorithm for HPV-Associated Cancer of Unknown Primary.
Kevin Kalinsky	04/30/2026	Journal of the Academy of Nutrition and Dietetics	¡Mi Vida Saludable!: Results of a Randomized, Controlled, 2 × 2 Factorial Trial of an In-Person and eHealth Diet and Physical Activity Intervention in Latina Breast Cancer Survivors.
Bradley C Carthon	04/30/2026	The Prostate	Phase II Randomized Study of MK-2206 and Bicalutamide in Prostate Cancer Patients With Rising PSA After Primary Therapy (ECOG-ACRIN E2809).

April 202633 publications

Authors	Date Published	Journal	Title
Olumide B Gbolahan	04/29/2026	Journal of gastrointestinal oncology	Intrahepatic cholangiocarcinoma: the equity gap in one of the most lethal cancers.
Ravi B Parikh	04/26/2026	Nature medicine	The arrival of digital twins and in silico trials in drug development.
Olatunji B Alese Olumide Gbolahan	04/23/2026	Biological research for nursing	Gut Microbiome and Psychoneurological Symptoms Among Patients With Colorectal Cancer and Their Caregivers: A Pilot Study.
Ravi B Parikh	04/22/2026	The New England journal of medicine	Utah's Prescription-Renewal Pilot Program - Autonomous AI Managing Patient Care.
Neil M Iyengar	04/20/2026	JAMA	Obesity and Cancer: A Translational Science Review.
Ravi B Parikh	04/20/2026	JAMA	Rewriting the Narrative on the Oncology Care Model.
William L Read	04/17/2026	Journal of clinical oncology : official journal of the American Society of Clinical Oncology	Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.
Jacqueline T Brown Bassel Nazha Jacob E Berchuck Ravi Bharat Parikh Jordan Alana Ciuro Omer Kucuk Bradley Curtis Carthon Mehmet Asim Bilen	04/14/2026	Cancer	Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617.
Jacob E Berchuck	04/14/2026	Clinical cancer research : an official journal of the American Association for Cancer Research	ctDNA Dynamics and Recurrence Patterns after Organ-Sparing Trimodality Therapy for Bladder Cancer.
Ravi B Parikh	04/14/2026	NPJ digital medicine	Advancing FDA New Approach Methodologies from animal models through digital twins.
Suresh S Ramalingam	04/13/2026	Proceedings of the National Academy of Sciences of the United States of America	Selective depletion of virus-specific CD8 T cells from the liver after PD-1 therapy with Fc-intact antibody during chronic infection.
Jacob E Berchuck	04/12/2026	Cancer cell	Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer.
Suresh S Ramalingam	04/11/2026	European journal of cancer (Oxford, England : 1990)	Patient-reported outcomes from the LAURA study: osimertinib in patients with unresectable stage III EGFR-mutated non-small cell lung cancer after definitive chemoradiotherapy.
Olatunji B Alese	04/09/2026	Journal of clinical oncology : official journal of the American Society of Clinical Oncology	Reply to: Delta-Like Ligand 3 Expression Across Lung Neuroendocrine Subtypes: Interpreting Response in Small Cell Lung Cancer and Beyond.
Ravi B Parikh	04/09/2026	The oncologist	OncoEducate: a pilot study of generative AI to enhance patient-clinician communication in genitourinary cancer care.
Dong M Shin Conor E Steuer Nabil F Saba	04/05/2026	Head & neck	Colocated Multidisciplinary Clinic Is Associated With Improved Timeliness to Postoperative Adjuvant Therapy in Head and Neck Cancer Patients.
Olatunji B Alese	04/01/2026	Cancer research	High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma.
Ravi B Parikh	04/01/2026	Journal of geriatric oncology	Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70): Protocol for a hybrid implementation-effectiveness study in three community oncology practices in the United States.
Conor Steuer Nabil F Saba	03/31/2026	American journal of clinical oncology	Evaluation of Neutrophil to Lymphocyte Ratio in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With a Combination of Cetuximab and Nivolumab in a Phase II Clinical Trial.
Neil M Iyengar	03/31/2026	Cancer discovery	A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.
Kevin Kalinsky	03/31/2026	Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	Sociodemographic Disparities in First-Line Treatment and Outcome Patterns in Women with HR+/HER2- Metastatic Breast Cancer.
Jacqueline T Brown Bassel Nazha Omer Kucuk	03/31/2026	Cancer medicine	Phase II Trial of Opaganib Addition in Metastatic Castration-Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide.
Jane L Meisel	03/31/2026	Clinical nuclear medicine	Negative 18 F-FES PET/CT Despite Estrogen Receptor Positivity by Immunohistochemistry.
Omer Kucuk Mehmet A Bilen	03/31/2026	European urology	[<sup>18</sup>F]-Fluciclovine or [<sup>68</sup>Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 Trial.
Ticiana Leal	03/31/2026	Future oncology (London, England)	SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in <i>KRAS</i> G12C NSCLC.
Ravi Bharat Parikh	03/31/2026	Health services research	A Machine Learning Model to Improve Risk Adjustment Accuracy in Medicare.
Olatunji B Alese	03/31/2026	JCO precision oncology	Nivolumab Plus Ipilimumab in Patients With Solid Tumors With High Tumor Mutation Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
Olatunji B Alese	03/31/2026	JCO precision oncology	Pertuzumab and Trastuzumab in Patients With <i>ERBB2/3</i>-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry Study.
Olatunji B Alese	03/31/2026	JCO precision oncology	Temsirolimus in Patients With Solid Tumors With <i>PIK3CA</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Nabil F Saba	03/31/2026	Journal of clinical oncology : official journal of the American Society of Clinical Oncology	Systemic Treatment of Thyroid Cancer: ASCO Guideline.
Mehmet A Bilen	03/31/2026	Journal of immunotherapy and precision oncology	Emerging Therapeutic Strategies in Metastatic Hormone-Sensitive Prostate Cancer.
Suresh S Ramalingam	03/31/2026	Lung cancer (Amsterdam, Netherlands)	Participation in lung cancer biospecimen studies: an analysis of the ECOG-ACRIN phase 3 E1505 and E5508 clinical trials.
Nabil F Saba	03/31/2026	Oral oncology	An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion).

March 202618 publications

Authors	Date Published	Journal	Title
Shipra Gandhi	03/30/2026	Clinical cancer research : an official journal of the American Association for Cancer Research	Computationally Derived Spatial Immune Signature Identifies Trastuzumab Responders in HER2+ Breast Cancer: NSABP B41 Clinical Trial Validation.
Mehmet A Bilen	03/30/2026	JCI insight	AURKA inhibitor VIC-1911 induces mitotic defects and functional BRCAness, sensitizing prostate cancer to PARP inhibition.
Shipra Gandhi	03/30/2026	Journal of the National Comprehensive Cancer Network : JNCCN	BIO26-046: Validating an LLM for Detecting Enrollment Disparities in Breast Cancer Trials.
Nabil F Saba	03/29/2026	Annals of surgical oncology	HPV-Associated Oropharyngeal Squamous Cell Carcinoma - Key Updates to the AJCC/UICC TNM9 Staging System.
Suresh S Ramalingam	03/29/2026	Future oncology (London, England)	A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.
Nabil F Saba	03/26/2026	Diagnostics (Basel, Switzerland)	HPV Detection in Oropharyngeal Cancer: A Narrative Review of Diagnostic and Emerging Molecular Approaches.
Jennifer W. Carlisle	03/26/2026	Journal of the National Comprehensive Cancer Network	HSR26-256: Real-World Evidence of Predictors of Time to Amifampridine Discontinuation and Survival in Patients With Cancer–Associated and Non-Cancer–Associated Lambert-Eaton Myasthenic Syndrome in the United States
Ruth L Sacks	03/25/2026	Head & neck	Quality Improvement Intervention to Improve Head and Neck Cancer Care in Safety Net Hospital Settings: Outcomes From a Single-Visit Multidisciplinary Clinic Model.
Jennifer W Carlisle Suresh S Ramalingam	03/24/2026	Nature	Exposed phosphatidylserine is an inhibitory molecule in T cell exhaustion.
Neil M Iyengar	03/23/2026	Cell reports	Large adipocytes increase vesicle-mediated lipid release and promote breast cancer malignancy.
Nabil F Saba	03/19/2026	International journal of molecular sciences	Liquid Biopsies in HNSCC: Current Landscape and Emerging Opportunities in the Era of HPV Stratification.
Kelsey Pan Badi El Olsta Dong M Shin Fatemeh Ardeshir-Larijani	03/16/2026	Cancer immunology, immunotherapy : CII	Thymic epithelial tumors at the crossroads of immunity, autoimmunity, and immunotherapy.
Nabil F Saba Conor E Steuer Dong M Shin	03/14/2026	Cancer	A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).
Jane Meisel Kevin Kalinsky	03/13/2026	Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	Comprehensive Clinicopathologic Evaluations of 149 Metaplastic Carcinomas of the Breast Treated With Neoadjuvant and Adjuvant Chemotherapy.
Suresh S Ramalingam	03/05/2026	Cancer discovery	ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib.
K Kalinsky	03/03/2026	ESMO open	Imlunestrant plus abemaciclib versus fulvestrant plus abemaciclib in ER-positive, HER2-negative advanced breast cancer: an indirect treatment comparison of three phase III trials.
Mehmet A Bilen	02/28/2026	Clinical genitourinary cancer	Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database.
Ravi B Parikh	02/28/2026	Clinical lung cancer	Real-World Effectiveness of Second-Line Therapies in Advanced Non-Small Cell Lung Cancer: Insights From Propensity-Weighted Comparative Analyses of Longitudinal EHR Data.

February 202620 publications

Authors	Date Published	Journal	Title
Olatunji B Alese Olumide Gbolahan	02/27/2026	Cancer letters	A phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling.
Ravi B Parikh	02/18/2026	BMC medical research methodology	Mapping eligibility criteria in oncology target trial emulations using real-world data: a scoping review.
Ticiana A Leal Suresh S Ramalingam	02/15/2026	The Journal of clinical investigation	Cotargeting DNA topoisomerase II enhances efficacy of RAS-targeted therapy in KRAS-mutant cancer models.
Jacob E Berchuck	02/14/2026	Cancer	Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel.
Daniel M Halperin	02/11/2026	Current oncology (Toronto, Ont.)	Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine Tumor.
Kevin Kalinsky	02/10/2026	Research square	Identification of Early Symptoms Associated with Subsequent Immune-related Adverse Events in the I-SPY clinical trial.
Bassel Nazha	02/04/2026	The oncologist	Age- and sex-based differences in the genomic profiles of patients with gastrointestinal and pancreatic neuroendocrine neoplasms.
Jacqueline T Brown Bassel Nazha Jacob E Berchuck Ravi Bharat Parikh Jordan Alana Ciuro Omer Kucuk Bradley Curtis Carthon Mehmet Asim Bilen	02/04/2026	The oncologist	Clinical outcomes of lutetium-177-PSMA-617 in a racially diverse cohort of patients with metastatic castration-resistant prostate cancer.
Nabil F Saba	02/03/2026	Clinical cancer research : an official journal of the American Association for Cancer Research	Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.
Nabil F Saba	02/01/2026	Journal of the National Cancer Institute	Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group review.
Jacob E Berchuck	02/01/2026	The Journal of clinical investigation	Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinoma.
J Meisel	01/31/2026	Annals of oncology : official journal of the European Society for Medical Oncology	Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13).
K Kalinsky	01/31/2026	Annals of oncology : official journal of the European Society for Medical Oncology	Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy.
Jose A Monteiro Nabil F Saba	01/31/2026	Cancer	Integrating systemic therapy into larynx preservation: Lessons from 3 decades of progress.
Nabil F Saba	01/31/2026	Future oncology (London, England)	JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC.
Kevin Kalinsky	01/31/2026	JAMA oncology	Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial.
Suresh S Ramalingam	01/31/2026	JTO clinical and research reports	Biomarker Testing and Patterns of Treatment in Patients with NSCLC: An International Association for The Study of Lung Cancer Analysis of American Society of Clinical Oncology CancerLinQ Discovery Data.
Nabil F Saba	01/31/2026	Otolaryngologic clinics of North America	Novel Treatment Approaches in Recurrent/Metastatic Squamous Head and Neck Cancer.
Mehmet Asim Bilen	01/31/2026	Trends in cancer	Mapping heterogeneity in the tumor microenvironment of renal cell carcinoma through single-cell omics.
Shipra Gandhi	01/31/2026	World journal of oncology	Neurotoxicity of Immunotherapy: Immune Checkpoint Inhibitor-Related Encephalitis vs. Immune Effector Cell-Associated Neurotoxicity Syndrome.

January 202629 publications

Authors	Date Published	Journal	Title
Dong M Shin Conor E Steuer Nabil F Saba	01/30/2026	Translational cancer research	Survival and response outcomes in patients with recurrent/metastatic head and neck cancer treated with opioids and statins: an exploratory pilot study.
Manali Bhave Kevin Kalinsky Shipra Gandhi	01/21/2026	Breast cancer research : BCR	Caution over haste: why novel endocrine therapy in early lines should wait in Estrogen receptor positive human epidermal growth factor receptor 2 negative breast cancer.
Kevin Kalinsky	01/21/2026	The New England journal of medicine	Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.
Nabil F Saba	01/18/2026	Cancers	Quantitative Imaging Advances in HPV-Positive Oropharyngeal Carcinoma.
Jacqueline T Brown Bassel Nazha Jordan Ciuro Bradley C Carthon Omer Kucuk Mehmet A Bilen	01/16/2026	The oncologist	An increase in splenic volume after first-line immunotherapy is associated with worse PFS in patients with metastatic renal cell carcinoma.
Nabil F Saba	01/15/2026	The Laryngoscope	Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRP.
Manali Bhave	01/06/2026	JCO oncology practice	Real-World Treatment Patterns and Outcomes for Patients With Metastatic Triple-Negative Breast Cancer in the United States: An Observational Study.
Kevin Kalinsky	01/05/2026	Clinical cancer research : an official journal of the American Association for Cancer Research	Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer.
Kevin Kalinsky	01/05/2026	Clinical cancer research : an official journal of the American Association for Cancer Research	PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.
Ravi B Parikh	01/01/2026	JAMA network open	Deep-Learning Serial CT Prediction of Survival in Immunotherapy-Treated Non-Small Cell Lung Cancer.
Ravi B Parikh	01/01/2026	JAMA network open	Epistemic Equity in Oncology Trials-Lessons From Nasopharyngeal Cancer.
Mehmet A Bilen	12/31/2025	Advances in therapy	Response to Letter to the Editor Regarding: 'Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'.
Mehmet A Bilen	12/31/2025	CA: a cancer journal for clinicians	Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.
Jacqueline T Brown	12/31/2025	Cancer	Molecular alteration profiles characterize intraductal carcinoma of the prostate.
Jane L Meisel	12/31/2025	Contemporary clinical trials	Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD.
Ravi B Parikh	12/31/2025	EClinicalMedicine	Prioritizing human-centered cancer care in a digital era.
Mehmet Asin Bilen	12/31/2025	Frontiers in immunology	Real-world incidence of G3-G4 adverse events in patients with advanced renal cell carcinoma receiving immune-combinations (ARON-1).
Kenneth Ogan Mehmet A Bilen	12/31/2025	Frontiers in oncology	Case Report: Looks can deceive: acute postoperative progressive renal dysfunction and hyperkalemia without significant hydronephrosis.
Jacqueline T Brown	12/31/2025	Frontiers in oncology	Surgical management of metastatic squamous cell carcinoma of the bladder: a case report and review of the literature.
Jane Meisel	12/31/2025	Future oncology (London, England)	OPERA-01: a phase III study of palazestrant for ER+, HER2- advanced breast cancer after CDK4/6 inhibitor therapy.
Kevin Kalinsky	12/31/2025	Integrative cancer therapies	A Retrospective Assessment of Symptom Reduction With Group Acupuncture at an NCI-Designated Comprehensive Cancer Center.
Olumide B Gbolahan	12/31/2025	JAMA internal medicine	Sexual Health in Cancer Care-A Gap in Understanding.
Olatunji B Alese	12/31/2025	JCO precision oncology	Olaparib in Patients With Solid Tumors With <i>ATM</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Olatunji Alese	12/31/2025	Journal of hepatology	Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma.
Kevin M Kalinsky	12/31/2025	Journal of patient experience	A Patient-Led Survey of Antibody Drug Conjugate Usage and Dosing for People Living With Metastatic Breast Cancer.
Jennifer Carlisle	12/31/2025	Lung cancer (Amsterdam, Netherlands)	A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS.
Ravi Parikh	12/31/2025	NAM perspectives	Toward a National Health Digital and Data Architecture: Laying the Foundation for Digital Transformation: Commission on Investment Imperatives for a Healthy Nation.
Mehmet A Bilen	12/31/2025	Therapeutic advances in medical oncology	Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancer.
Mehmet A Bilen	12/31/2025	Urologic oncology	Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study.

Authors	Date Published	Journal	Title